"By using this technology, we can restore tumor suppressor gene expressions such as PTEN, P53, or tumor antigens for immunotherapy while simultaneously knocking down the genes/proteins involved in ...

10 years after its identification, the tumour suppressor phosphatase and tensin homologue (PTEN) still holds lots of surprises. Three studies, published in Cell, provide insights into how ...

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. | ITV National News ...